LivingGLP1
Study S003227

Pharmacokinetics of Benaglutide Injection in Overweight/Obese Adults

ClinicalTrials.gov record

Registration

Registration
NCT05226000
Study type
INTERVENTIONAL
Phase
PHASE1
Masking
NONE
Status
COMPLETED
Enrollment
16
Start
2020-07-07
Primary completion
2020-12-01
Lead sponsor
The Affiliated Hospital of Qingdao University
Conditions
Overweight/Obese Adults
Interventions
DRUG:Benaglutide Injection
Results posted
FALSE

Registered primary outcomes

  • Peak Plasma Concentration (Cmax) [80 days]
  • Area under the plasma concentration versus time curve (AUC)0-t [80 days]
  • Area under the plasma concentration versus time curve (AUC)0-∞ [80 days]
  • elimination half-life time(T1/2) [80 days]
  • The total clearance(CL) [80 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.